retatrutide clinical results vs Tirzepatide (2026): Differences in Weight Loss, Metabol – Revolution Health & Wellness Retatrutide Results: 28.3% Weight Loss
Description
When the stomach slows down or stops moving, this digestion process slows down

SUSTAIN-6 showed that semaglutide reduced major adverse cardiovascular events by 26%

Quick Answer: GLP-1-related bloating can be reduced through smaller frequent meals, avoiding high-fat and gas-producing foods, eating slowly, gentle post-meal walking, and dose adjustment strategies under medical supervision

Additionally, if gastrointestinal side effects persist beyond the first 8-12 weeks of treatment or worsen over time rather than improving, discuss this with your provider, as it may indicate the need for alternative treatment approaches

Providers should monitor their state Medicaid program for policy updates
Journal of clinical hypertension (Greenwich, Conn) 2016;18(6):51421
